Pancreatic Cancer Research

ResearcherUniversity of LondonNo recent work listed

Androulla Elia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1236-2079; OpenAlex author ID A5057395376. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment. Last author DOI 10.3390/ijms23147810↗
  2. Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Co-author DOI 10.1038/s41419-017-0001-z↗
  3. Role of the eIF4E binding protein 4E-BP1 in regulation of the sensitivity of human pancreatic cancer cells to TRAIL and celastrol-induced apoptosis. Last author DOI 10.1111/boc.201300021↗
  4. Treatment with IMM-101 induces protective CD8+ T cell responses in clinically relevant models of pancreatic cancer Co-author DOI 10.1186/2051-1426-1-s1-p215↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ella F. Rimmer · 1 shared paper, 2022 · strength 0.20
  2. Satvinder Mudan · 2 shared papers, 2013–2017 · strength 0.11
  3. Stéphane Pyronnet · 1 shared paper, 2017 · strength 0.07
  4. Laura Rosa Brunet · 1 shared paper, 2013 · strength 0.05
  5. Thorsten Hagemann · 1 shared paper, 2013 · strength 0.05
  6. Reka Chakravarthy · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.